Second Primary Pancreatic Adenocarcinoma Three Years After Successfully Treated Index Esophageal Cancer

  • Nina Nandy Department of Internal Medicine, University of Connecticut. Farmington CT, USA
  • Constantin A Dasanu Medical Oncology and Blood Disorders, Department of Hematology-Oncology, Saint Francis Hospital and Medical Center. Hartford CT, USA
Keywords: Adenocarcinoma, Esophageal Neoplasms, Neoplasms, Second Primary, Pancreatic Neoplasms

Abstract

Context Development of a second primary malignancy after an index esophageal cancer is a rare event, primarily due to short survival of patients with esophageal cancer. However, the number of long-term esophageal cancer survivors has been increasing due to advances in early detection and therapy. Case report We report herein a case of pancreatic adenocarcinoma that developed three years after a successfully treated early-stage adenocarcinoma of the esophagus. A 70-year-old Caucasian male presented with vague complaints of nausea, vomiting and abdominal distention, with subsequent development of jaundice. A computed tomography scan of abdomen revealed a 2.9 cm soft tissue mass in the head of the pancreas and the patient underwent a Whipple’s procedure, with pathology confirming the diagnosis of pancreatic adenocarcinoma. Three years previously, the patient was successfully treated for adenocarcinoma of the esophagus via minimally invasive esophagogastrectomy. Despite chemoradiotherapy for localized disease and subsequent systemic chemotherapy for metastatic pancreatic cancer, the patient eventually succumbed to his illness. Conclusion We discuss the association between esophageal cancer and subsequent second malignancies, along with implications for surveillance and therapy.

Image: A low-attenuation mass in the head of the pancreas and uncinate process.

Downloads

Download data is not yet available.

References

Matsubara T, Yamada K, Nakagawa A. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003; 21: 4336- 4341.

Goodner J, Watson W. Cancer of the esophagus. Cancer 1956; 9: 1248-1252.

Bosch A, Frias Z, Caldwell W, et al. Autopsy findings in carincoma of the esophagus. Acta Radiol Oncol 1979; 18: 103-112.

Shibuya H, Takagi J, Horiuchi S, et al. Carcinoma of the esophagus with synchronous or metachronous primary carcinomas in other organs. Acta Radiol Oncol 1982; 21: 39-43.

Fogel TD, Harrison LB, Son YH. Subsequent upper aerodigestive malignancies following treatment of esophageal cancer. Cancer 1985; 55: 1882-1885.

Poon R, Law S, Chu K, et al. Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications. Ann Thorac Surg 1998; 65: 1529-1534.

Abo S, Miura H, Kudo T, et al. Concurrent cancer of the esophagus and other organ in Japan. Jpn J Gastroenterol Surg 1980; 13: 377-381.

Kagei K, Hosokawa M, Shirato H, et al. Efficacy of intense screening and treatment for synchronous second primary cancers in patients with esophageal cancer. Jpn J Clin Oncol 2002; 32: 120-127.

Koide N, Yazawa K, Koike S, et al. Oesophageal cancer associated with other primary cancers: a study of 131 patients. J Gastroenterol and Hepatol 1997; 12: 690-694.

Zhu G, Chen Y, Zhu Z, et al. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries. Diseases of the Esophagus 2012; 25: 505-511.

Chaung S, Hashibe M, Scelo G, et al. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev 2008; 17: 1543-1549.

Das A, Thomas S, Zablotska LB, et al. Association of esophageal adenocarcinoma with other subsequent primary cancers. J Clin Gastroenterol 2006; 40; 405-411.

Van Rees BP, Cleton-Jansen AM, Cense HA, et al. Molecular evidence of field cancerization in a patient with 7 tumors of the aerodigestive tract. Hum Pathol 2000; 31: 269-271.

Graham TA, McDonald SA, Wright NA. Field cancerization in the GI tract. Future Oncol. 2011 Aug;7(8):981-993.

Zhu G, Chen Y, Zhu Z, et al. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries. Diseases of the Esophagus 2012; 25: 505-511.

Shi X, Liu L, Din Q. A study on the CD(4) (+) CD (25) (+) regulatory T cells in patients with gastrointestinal malignancies. Med Oncol 2009; 4: 471-475.

Somja J, Demoulin S, Roncarati P et al. Dendritic cells in Barrett’s esophagus carcinogenesis: an inadequate microenvironment for antitumor immunity? Am J Pathol 2013; 182: 2168-2179.

Abo S, Miura H, Kudo T, et al. Concurrent cancer of the esophagus and other organ in Japan. Jpn J Gastroenterol Surg 1980; 13: 377-381.

A low-attenuation mass in the head of the pancreas and uncinate process
Published
2014-01-10
How to Cite
NandyN., & DasanuC. (2014). Second Primary Pancreatic Adenocarcinoma Three Years After Successfully Treated Index Esophageal Cancer. JOP. Journal of the Pancreas, 15(1), 46-48. https://doi.org/10.6092/1590-8577/1892
Section
CASE REPORTS